glp 1 receptor agonist heart failure Effects of GLP-1 Agonists in Patients The effect of GLP-1 receptor

Some findings suggest a potential link between these medications and diabetic retinopathy progression, particularly in patients with pre-existing eye conditions

SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE

The most common problems were gastrointestinal, including nausea and vomiting

A notable study showcased that participants receiving GLP-1 agonists reported a mean weight loss ranging between 3.0 and 3.6 kg over six months

Administrative, technical or material support: all authors

For context on adjacent metabolic research tools, the 5-Amino-1MQ Research Guide UK 2026: NNMT Inhibition & Metabolic Studies provides a complementary perspective on non-incretin metabolic pathways under active investigation